Retinal photocoagulation for proliferative sickle cell retinopathy: a prospective clinical trial with new sea fan classification

Eur J Ophthalmol. 2008 Mar-Apr;18(2):248-54. doi: 10.1177/112067210801800213.

Abstract

Purpose: To compare the clinical outcome of stage III proliferative sickle cell retinopathy (PSR) treated by peripheral retinal scatter photocoagulation to natural course disease.

Methods: Long-term follow-up of 101 patients enrolled in a prospective trial of photocoagulation for PSR has been completed. Among 202 eyes of 101 patients enrolled at the University Eye Clinic of Créteil, 73 eyes showed a stage III PSR, which the authors further divided into five new grades (A, B, C, D, E) considering size, hemorrhage, fibrosis, and visible vessels. Grading was based on a three-mirror fundus examination, 360 degrees color photographs, and fluorescein angiography. Mean follow- up was 4 years.

Results: Thirty-eight treated eyes and 35 untreated eyes were included in this study. The evolution was not statistically significant between treated and untreated groups concerning flat sea fan <1 MPS disc area (grade A) or elevated sea fan with partial fibrosis (grade C). Progression and regression were compared between the two groups for grade B, resulting statistically significant (p<0.05). Nine complications (13%) were observed, which only occurred in untreated patients with elevated sea fan and hemorrhage (grade B) or complete fibrosed sea fan with well defined vessels (grade E) (p<0.05).

Conclusions: These data suggest that patients with grade A or C new sea fan classification should not be initially treated but observed.

Publication types

  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Adult
  • Disease Progression
  • Female
  • Fluorescein Angiography
  • Follow-Up Studies
  • Hemoglobin SC Disease / classification
  • Hemoglobin SC Disease / surgery*
  • Humans
  • Laser Coagulation*
  • Male
  • Middle Aged
  • Prospective Studies
  • Retinal Neovascularization / classification*
  • Retinal Neovascularization / surgery*
  • Sickle Cell Trait / classification
  • Sickle Cell Trait / surgery*
  • Treatment Outcome
  • Vitreous Hemorrhage / classification
  • Vitreous Hemorrhage / surgery*
  • beta-Thalassemia / classification
  • beta-Thalassemia / surgery*